Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 120

Sort by

Sort Order Select

Journal Articles

Repurposing of disulfiram as a novel therapeutic agent to treat crebbp-mutant diffuse large B-cell lymphoma (DLBCL)

James Boncan, Lili Dimitrova, Priyankush Choudhury, Lakshmi Rajput, Kianoosh Sateri, Eleni Maniati, Jun Wang, John Marshall, Andrew Finch, Barrie Peck

Blood (2025) 146 (Supplement 1): 1524.

https://doi.org/10.1182/blood-2025-1524

Published: 2025

Journal Articles

Benchmark evaluation of large language models in acute myeloid leukemia prognosis

Xiangjie Lin, Di Xu, Nanfang Zhuo, Jingrui Jin, Yujia Wang, Liping Mao, Yinjun Lou, Min Yang, Haitao Meng, Wanzhuo Xie, Jian Huang, Hongyan Tong, Shengli Xue, Yu Zhu, Jie Jin, Jun Wang, Huafeng Wang

Blood (2025) 146 (Supplement 1): 7954.

https://doi.org/10.1182/blood-2025-7954

Published: 2025

Journal Articles

Study on the efficacy and safety of HDAC inhibitor combined with venetoclax and azacitidine in the treatment of adult T-ALL

Jiyi Fu, Boyue Zheng, Jun Wang, Jiafei Wu, Hong Zheng, Xiaobing Huang, Xi Yang, Li Hui

Blood (2025) 146 (Supplement 1): 1579.

https://doi.org/10.1182/blood-2025-1579

Published: 2025

Journal Articles

Efficacy and prognosis of venetoclax combined with the 3+7 regimen in fit AML: A propensity score-matched cohort study

Boyue Zheng, Jiyi Fu, Jun Wang, Jiafei Wu, Xi Yang, Xiaobing Huang, Hong Zheng, Li Hui

Blood (2025) 146 (Supplement 1): 3463.

https://doi.org/10.1182/blood-2025-3463

Published: 2025

Journal Articles

Orelabrutinib combined with R-CDOP regimen for first-line treatment of diffuse large B-cell lymphoma with high-risk CNS-IPI

Xibin Xiao, Wenbin Qian, Lixia Sheng, Jun Wang, Huyi Lei, Xian Li, Jing Xie, Changqian Bao, Huawei Jiang

Blood (2025) 146 (Supplement 1): 5460.

https://doi.org/10.1182/blood-2025-5460

Published: 2025

Journal Articles

Transcriptional Regulation of Cytotoxic T-Cell Responses in Acute Myeloid Leukemia

Xufeng Chen, Zhengxi Sun, Jana Elegast, Hua Zhou, Soobeom Lee, Deedra Nicolet, Qiao Lu, Kun Wang, Jun Wang, Wafa Al-Santli, Ann-Kathrin Eisfeld, Kimberly Stegmaier, Iannis Aifantis, Rebecca Austin

Blood (2024) 144 (Supplement 1): 5733.

https://doi.org/10.1182/blood-2024-193591

Published: 2024

Journal Articles

MYD88 Mutations in Chronic Lymphocytic Leukemia Exhibit Distinct Biological Behaviors and Prognostic Implications

Yuting Yan, Yulan Zhou, Weihao Chen, Jun Wang, Tingyu Wang, Ying Yu, Yujiao Jia, Zhen Yu, Lugui Qiu, Fei Li, Shuhua Yi

Blood (2024) 144 (Supplement 1): 4624.

https://doi.org/10.1182/blood-2024-207323

Published: 2024

Journal Articles

Sirolimus Plus Roxadustat in Patients with Pure Red Cell Aplasia: Results from a Prospective Multi-Center Clinical Trial

Blood (2024) 144 (Supplement 1): 3838.

https://doi.org/10.1182/blood-2024-201926

Published: 2024

Journal Articles

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

Bian Renjie, Yi Qu, Danyang Wu, Jinxiang Yu, Xiaoxue Wang, Lei Wang, Juan He, Jun Wang, Xiaojing Yan

Blood (2024) 144 (Supplement 1): 6466.

https://doi.org/10.1182/blood-2024-204890

Published: 2024

Journal Articles

A Novel JAK2 Inhibitor OB756 in Treatment of Janus Kinase Inhibitor-Naive Patients with Myelofibrosis: A Phase 1/2, Open-Label, Multicenter Study

Blood (2024) 144 (Supplement 1): 1808.

https://doi.org/10.1182/blood-2024-212216

Published: 2024

Journal Articles

Exploring Prognostic Factors of Venetoclax Combined with Azacitidine in Unfit AML Based on Real-World Data from a Chinese Population

Boyue Zheng, FU JIyi, Jiafei Wu, Wang Yu, Jun Wang, Chuanyan Jiang, Wang Huan, Yang Haiqing, Xi Yang, Hong Zheng, Li Hui

Blood (2024) 144 (Supplement 1): 5948.

https://doi.org/10.1182/blood-2024-205623

Published: 2024

Journal Articles

Daunorubicin 90 Mg/m2 and 60 Mg/m2 Demonstrates Comparable Efficacy, Safety Profiles, and Long-Term Outcomes in Chinese Patients with Newly Diagnosed Acute Myeloid Leukemia

Jinhui He, Patrick Chu, Jiacai Zhuo, Hua Yang, Jun Wang, Huijun Li, Jing Huang, Yun Ma, Xiaojuan An, Miaoling Qiu, Xiaoling Qiu, Chun Feng, Jiahe Zhang, Guoqiang Li, Junjie Hou, Xiao Qiu, Siwan Zhang, Jihao Zhou

Blood (2024) 144 (Supplement 1): 6031.

https://doi.org/10.1182/blood-2024-200603

Published: 2024

Journal Articles

Determination of MYD88 and CXCR4 Mutation for Clinical Detection and Their Significance in Waldenström Macroglobulinemia

Blood (2024) 144 (Supplement 1): 4349.

https://doi.org/10.1182/blood-2024-202324

Published: 2024

Journal Articles

CD39, CD73 and the Adenosine Pathway Mediate Immune Escape in Juvenile Myelomonocytic Leukemia (JMML)

Jovana Rajak, Ke Meng, Anna Lena Stippel, Jun Wang, Naile Koleci, Alexandra Emilia Schlaak, Hui Xiao, Christian Flotho, Charlotte Marie Niemeyer, Bertram Bengsch, Miriam Erlacher

Blood (2024) 144 (Supplement 1): 4514.

https://doi.org/10.1182/blood-2024-209744

Published: 2024

Journal Articles

The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients

Blood (2023) 142 (Supplement 1): 4302.

https://doi.org/10.1182/blood-2023-174891

Published: 2023

Journal Articles

The Incidence, Clinical Application and Prognostic Significance of MYD88 and CXCR4 Mutation in Chinese Patients with Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia

Ying Yu, Yuting Yan, Jun Wang, Wenjie Xiong, Yao Yao, Yanshan Huang, Rui Lyu, Tingyu Wang, Qi Wang, Wei Liu, Gang An, Weiwei Sui, Yan Xu, Wenyang Huang, Dehui Zou, Zhijian Xiao, Lugui Qiu, Shuhua Yi

Blood (2023) 142 (Supplement 1): 6089.

https://doi.org/10.1182/blood-2023-188786

Published: 2023

Journal Articles

Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML

Blood (2023) 142 (Supplement 1): 1389.

https://doi.org/10.1182/blood-2023-184516

Published: 2023

Journal Articles

Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation

Megan Perrett, Lucy Pickard, Emil Kumar, Giuseppe Palladino, Faraz Khan, Carina Edmondson, Connor Knight, Edward Poynton, Janet Matthews, Shamzah Araf, Andrew James Clear, Maria Calaminici, John G. Gribben, Hamish King, Mirjana Efremova, Jun Wang, Jessica Okosun

Blood (2022) 140 (Supplement 1): 748–749.

https://doi.org/10.1182/blood-2022-159995

Published: 2022

Journal Articles

Data of Daratumumab from a Real-World Single-Center Study

Jun Wang, Jiafei Wu, Xi Yang, Hong Zheng, Yijing Wang, Boyue Zheng, Feiyang Li, Hui Li

Blood (2022) 140 (Supplement 1): 12650.

https://doi.org/10.1182/blood-2022-170588

Published: 2022

Journal Articles

Outcome and Molecular Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia Patients with MEF2D Fusions

Kai Sun, Wen-Min Chen, Xu Wang, Xiao-Su Zhao, Ling-Di Li, Yue Hao, Jun Wang, Nan Xu, Hao Jiang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Qian Jiang, Xiao Jun Huang, Ya-Zhen Qin

Blood (2022) 140 (Supplement 1): 11864–11865.

https://doi.org/10.1182/blood-2022-159866

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Repurposing of disulfiram as a novel therapeutic agent to treat crebbp-mutant diffuse large B-cell lymphoma (DLBCL)

Benchmark evaluation of large language models in acute myeloid leukemia prognosis

Study on the efficacy and safety of HDAC inhibitor combined with venetoclax and azacitidine in the treatment of adult T-ALL

Efficacy and prognosis of venetoclax combined with the 3+7 regimen in fit AML: A propensity score-matched cohort study

Orelabrutinib combined with R-CDOP regimen for first-line treatment of diffuse large B-cell lymphoma with high-risk CNS-IPI

Transcriptional Regulation of Cytotoxic T-Cell Responses in Acute Myeloid Leukemia

MYD88 Mutations in Chronic Lymphocytic Leukemia Exhibit Distinct Biological Behaviors and Prognostic Implications

Sirolimus Plus Roxadustat in Patients with Pure Red Cell Aplasia: Results from a Prospective Multi-Center Clinical Trial

Prognosis Prediction By Two Single Factors Could Predict the Survival of PCNSL Patients Received HD-MTX Therapy without HSCT

A Novel JAK2 Inhibitor OB756 in Treatment of Janus Kinase Inhibitor-Naive Patients with Myelofibrosis: A Phase 1/2, Open-Label, Multicenter Study

Exploring Prognostic Factors of Venetoclax Combined with Azacitidine in Unfit AML Based on Real-World Data from a Chinese Population

Daunorubicin 90 Mg/m2 and 60 Mg/m2 Demonstrates Comparable Efficacy, Safety Profiles, and Long-Term Outcomes in Chinese Patients with Newly Diagnosed Acute Myeloid Leukemia

Determination of MYD88 and CXCR4 Mutation for Clinical Detection and Their Significance in Waldenström Macroglobulinemia

CD39, CD73 and the Adenosine Pathway Mediate Immune Escape in Juvenile Myelomonocytic Leukemia (JMML)

The XPO1-FOXC1-HOX Functional Axis Opens New Therapeutic Avenues to Treat DEK-NUP214 AML Patients

The Incidence, Clinical Application and Prognostic Significance of MYD88 and CXCR4 Mutation in Chinese Patients with Lymphoplasmacytic Lymphoma/ Waldenström Macroglobulinemia

Allele-Specific Expression of Leukemia Genes Is Associated with Pathogenicity in Poor Risk AML

Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation

Data of Daratumumab from a Real-World Single-Center Study

Outcome and Molecular Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia Patients with MEF2D Fusions

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only